C1抑制剂缺陷增强接触途径介导的凝血激活和静脉血栓形成
研究利用C1INH-HAE患者血浆和C1INH缺陷小鼠模型,发现C1INH缺陷显著增强接触途径介导的凝血酶生成,小鼠基线凝血激活标志物升高,且静脉血栓形成增强而动脉血栓形成未增强,纯化人C1INH可逆转上述异常。
要点
- C1INH-HAE患者血浆接触途径介导的凝血酶生成显著增加。
- C1INH缺陷小鼠基线凝血酶原片段1+2和凝血酶-抗凝血酶复合物水平显著升高。
- C1INH缺陷小鼠静脉血栓形成显著增强,动脉血栓形成未见增强,纯化人C1INH可逆转。
核心结论
- 内源性C1INH是人和小鼠接触途径介导凝血的关键负调控因子,也是小鼠静脉血栓形成的重要负调控因子。
研究设计与样本
- 研究使用C1INH-HAE患者血浆样本和C1INH缺陷小鼠模型进行实验。
主要发现
- C1INH-HAE患者血浆接触途径介导的凝血酶生成显著增加。
- C1INH缺陷小鼠基线循环凝血酶原片段1+2和凝血酶-抗凝血酶复合物水平显著升高。
- C1INH缺陷小鼠全血支持接触途径介导的凝血酶生成显著增加。
- C1INH缺陷小鼠静脉血栓形成显著增强,动脉血栓形成未见增强。
- 纯化人C1INH使C1INH缺陷小鼠的接触途径介导凝血酶生成和静脉血栓形成恢复正常。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
C1 inhibitor (C1INH) is a multifunctional serine protease inhibitor that functions as a major negative regulator of several biological pathways, including the contact pathway of blood coagulation. In humans, congenital C1INH deficiency results in a rare episodic bradykinin-mediated swelling disorder called hereditary angioedema (HAE). Patients with C1INH deficiency-associated HAE (C1INH-HAE) have increased circulating markers of activation of coagulation. Furthermore, we recently reported that patients with C1INH-HAE had a moderate but significant increased risk of venous thromboembolism. To further investigate the impact of C1INH deficiency on activation of coagulation and thrombosis, we conducted studies using patient samples and mouse models. Plasmas from patients with C1INH-HAE had significantly increased contact pathway-mediated thrombin generation. C1INH-deficient mice, which have been used as a model of C1INH-HAE, had significantly increased baseline circulating levels of prothrombin fragment 1+2 and thrombin-antithrombin complexes. In addition, whole blood from C1INH-deficient mice supported significantly increased contact pathway-mediated thrombin generation. Importantly, C1INH-deficient mice exhibited significantly enhanced venous, but not arterial, thrombus formation. Furthermore, purified human C1INH normalized contact pathway-mediated thrombin generation and venous thrombosis in C1INH-deficient mice. These findings highlight a key role for endogenous C1INH as a negative regulator of contact pathway-mediated coagulation in humans and mice. Further, this work identifies endogenous C1INH as an important negative regulator of venous thrombus formation in mice, complementing the phenotype associated with C1INH-HAE.
引用
- Grover SP, Kawano T, Wan J, et al. C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. Blood. 2023. PMID: 36701760. doi:10.1182/blood.2022018849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。